
Insights and Takeaways for The Next Chapter in Specialty Medicine from Asembia AXS25
Guided by our values, we are an impact-driven organization that improves care in every setting – one product, one partner, one patient at a time.
Through our core commitments, we are leveraging our scale for the greater good, such as serving the needs of our stakeholders, donating back to our communities, protecting our planet, working with policymakers, and more.
Every year, we publish updates to our commitments through our Impact Report.
Download Our Impact ReportOur businesses bring together leading technologies, innovative solutions and hands-on expertise to support the entire healthcare ecosystem.
We distribute pharmaceuticals and medical supplies to healthcare settings across North America, from pharmacies and hospitals to doctors’ offices and clinics.
We help to ensure the financial wellbeing of pharmacies and health systems and support a stable work environment for their employees.
We provide research, insights, technologies and other support to help address challenges in cancer and specialty care.
We provide a suite of solutions designed to address access, affordability and adherence challenges by bridging the gaps between biopharma companies, pharmacies, providers, and payers to help patients get on and stay on their medications.
We offer solutions that enable employers, payers, health-plan brokers and government agencies to provide lower-cost options for prescription medications and therapies.
We help to ensure the financial wellbeing of pharmacies and health systems and support a stable work environment for their employees.
Every year, we publish updates to our commitments through our Impact Report.
Download Our Impact ReportA look back on the milestones and moments as McKesson distributed ancillary supply kits and vaccines as directed by the U.S. government.
Since the first COVID-19 vaccine doses and ancillary supply kits needed to administer them shipped out of our McKesson distribution centers last December – and even in the months leading up to that moment – our teams have worked nonstop to do their part in helping vaccinate our country and the world to curb the pandemic.
According to the Centers for Disease Control and Prevention (CDC), as of December 2021, we’ve delivered more than 246 million Moderna and Johnson & Johnson COVID-19 vaccine doses throughout the U.S. and significantly more of the ancillary supply kits that also support the Pfizer-BioNTech vaccine.
“As I reflect on the work that we've done and the work that we continue to do to support this pandemic response, perhaps the most incredible part of this program is that every dose that we distribute is a life that's potentially saved,” says Shawn Seamans, executive sponsor for McKesson’s COVID-19 Response. “It's the responsibility that we have – playing our part to save lives and to get our country back on track.”
More recently, we’ve begun shipping out boosters and the ancillary supply kits needed for children who are getting the vaccines. Additionally, we are continuing to support the U.S. government’s mission to provide vaccines to the world by preparing millions of doses for more than 30 countries and counting.
In addition to our distribution efforts, we’ve also helped to get shots in arms through Health Mart independent pharmacies, many of which operate in hard-to-reach rural communities. Since earlier this spring, 740 locations have been instrumental in reaching communities across 44 states through Health Mart’s Federal COVID-19 Vaccination Program. As of November, participating Health Mart pharmacies have administered more than 592,000 COVID-19 vaccine doses.
And while the pandemic continues, we’ve already taken in many lessons.
“The pandemic has taught us that when we share a mission, we can mobilize across departments, functions and business units with amazing speed and effectiveness,” says Stanton McComb, president of McKesson Medical-Surgical. “It is clear that it’s not just about what's happening in a community or in a state or even in a country. Pandemics clearly don’t recognize borders. Our response to the pandemic is also proving that private and public partnerships, between entities like McKesson and federal agencies like the Department of Health and Human Services work well. This gives me a lot of optimism for the future.”
As we reach this vaccine roll out milestone, here’s some of the images and stories from the past year of the people and initiatives that brought this moment in time to life.
Insights and Takeaways for The Next Chapter in Specialty Medicine from Asembia AXS25
Learn more about RxOwnership, McKesson’s strategic consultants who help independent pharmacy owners navigate challenges, optimize operations and achieve financial health.
From team volunteering to enterprise-wide events like GivingTuesday and Community Impact Days, our employees raised the bar in 2024 by making a difference in the communities where we live, work and serve.
Milken Institute Future of Health Summit panelists address critical industry challenges and explore ways to futureproof the pharmaceutical supply chain.
Learn how pharmacists are transforming patient health across settings.
Learn how the CoverMyMeds Pharmacy dispensing network enhances patient care and streamlines prescription fulfillment.
The powerful tool assists McKesson Medical-Surgical customers with optimizing operations and cost savings, and helps ensure a more resilient supply chain.
Learn how McKesson is turning hope into reality for patients in the communities we serve.
Learn how we’re utilizing our strengths to help build a healthier, more equitable future.
Learn how McKesson is helping to improve access to care through micro-access pharmacies.